Pulmonx Corporation (Nasdaq: LUNG) ('Pulmonx” or the 'Company'), a global leader in minimally invasive treatments for lung ...

Newswatch 16's Justin Gick spoke with a pulmonologist about the signs and symptoms of COPD and when to see a doctor.

Pulmonx is positioned at the bottom for Revenue Growth, with a negative growth rate. It is also at the bottom for Gross ...

Pulmonx Corporation ( ($LUNG) ) has released its Q3 earnings. Here is a breakdown of the information Pulmonx Corporation presented to its ...

Q3 2025 Earnings Call November 12, 2025 4:30 PM ESTCompany ParticipantsGlendon French - CEO, President & DirectorDerrick ...

COPD is a group of lung diseases that get worse over time. It prevents airflow to the lungs, causing breathing problems and ...

Please provide your email address to receive an email when new articles are posted on . In those with and those without a history of CVD/metabolic disease, patients receiving dupilumab vs. placebo had ...

AstraZeneca's hopes of a big new indication for respiratory drug Fasenra in chronic obstructive pulmonary disease (COPD) have been dashed by a negative phase 3 trial. The RESOLUTE study of IL-5 ...

Glen French, member of the Board of Directors and former Pulmonx President and Chief Executive Officer, reappointed President and Chief Executive OfficerDerrick Sung, former Pulmonx Chief Financial Of ...

REDWOOD CITY, Calif., Oct. 15, 2025 (GLOBE NEWSWIRE) -- (Nasdaq: LUNG) (“Pulmonx” or the "Company"), a global leader in minimally invasive treatments for lung disease, today announced that it will ...